These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 12009821

  • 1. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre.
    Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarr JJ, Raad II.
    J Hosp Infect; 2002 May; 51(1):52-8. PubMed ID: 12009821
    [Abstract] [Full Text] [Related]

  • 2. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.
    Cheng AC, Harrington G, Russo P, Liolios L, Spelman D.
    Intern Med J; 2004 Aug; 34(8):510-2. PubMed ID: 15317552
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E, Cataldo MA.
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [Abstract] [Full Text] [Related]

  • 4. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
    Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM.
    Clin Infect Dis; 2003 Aug 01; 37(3):326-32. PubMed ID: 12884155
    [Abstract] [Full Text] [Related]

  • 5. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
    Morris-Downes M, Smyth EG, Moore J, Thomas T, Fitzpatrick F, Walsh J, Caffrey V, Morris A, Foley S, Humphreys H.
    J Hosp Infect; 2010 Jul 01; 75(3):228-33. PubMed ID: 20363048
    [Abstract] [Full Text] [Related]

  • 6. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR.
    Arch Intern Med; 2003 Sep 08; 163(16):1905-12. PubMed ID: 12963563
    [Abstract] [Full Text] [Related]

  • 7. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK.
    Clin Infect Dis; 2000 Oct 08; 31(4):1058-65. PubMed ID: 11049790
    [Abstract] [Full Text] [Related]

  • 8. Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital.
    Wang JT, Chen YC, Chang SC, Chen ML, Pan HJ, Chang YY, Sun CC, Wang LH, Wang SH, Lin HC, Chien SF, Tseng MS.
    J Hosp Infect; 2004 Oct 08; 58(2):97-103. PubMed ID: 15474179
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin-resistant enterococci: consequences for therapy and infection control.
    Mascini EM, Bonten MJ.
    Clin Microbiol Infect; 2005 Jul 08; 11 Suppl 4():43-56. PubMed ID: 15953021
    [Abstract] [Full Text] [Related]

  • 10. [Vancomycin resistant Enterococci (VRE)].
    Lesens O.
    Nephrol Ther; 2009 Jun 08; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [Abstract] [Full Text] [Related]

  • 11. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
    Chavers LS, Moser SA, Funkhouser E, Benjamin WH, Chavers P, Stamm AM, Waites KB.
    Microb Drug Resist; 2003 Jun 08; 9 Suppl 1():S69-77. PubMed ID: 14633370
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
    Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW.
    Intensive Care Med; 2002 Jun 08; 28(6):692-7. PubMed ID: 12107672
    [Abstract] [Full Text] [Related]

  • 14. Control of vancomycin-resistant enterococci: one size fits all?
    Armeanu E, Bonten MJ.
    Clin Infect Dis; 2005 Jul 15; 41(2):210-6. PubMed ID: 15983917
    [Abstract] [Full Text] [Related]

  • 15. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
    Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, Pantelaki M, Siafakas N, Zerva L, Giamarellou H.
    Clin Microbiol Infect; 2008 Jan 15; 14(1):14-21. PubMed ID: 18005178
    [Abstract] [Full Text] [Related]

  • 16. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP.
    Infect Control Hosp Epidemiol; 2001 Jul 15; 22(7):437-42. PubMed ID: 11583213
    [Abstract] [Full Text] [Related]

  • 17. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
    McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, Mackin ML, Kauffman CA.
    Clin Infect Dis; 2006 Jan 15; 42(2):195-203. PubMed ID: 16355329
    [Abstract] [Full Text] [Related]

  • 18. [Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].
    Reale AL, Depetri ML, Culasso C, Paviolo M, Cheguirián ML, Enrico MC, Ledesma EM, Vidal C, Glatstein E, Bertoni L.
    Rev Argent Microbiol; 2009 Jan 15; 41(2):92-6. PubMed ID: 19623898
    [Abstract] [Full Text] [Related]

  • 19. Managing vancomycin-resistant enterococci. A winning team approach.
    Robinson K, Duff Z, Mercer J, Cran M, Gill-Morton P, Main S.
    Can Nurse; 1997 Nov 15; 93(10):36-9. PubMed ID: 9444145
    [Abstract] [Full Text] [Related]

  • 20. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD, Salgado CD, Durkalski VL, Bosso JA.
    Ann Pharmacother; 2008 Mar 15; 42(3):317-26. PubMed ID: 18285560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.